Skip to main content
logo
BioStem Technologies, Inc. (BSEM)
NASDAQ: BSEM · Real-Time Price · USD
3.680
+0.335 (10.01%)
At close: Aug 20, 2026, 4:00 PM EDT
3.730
+0.050 (1.36%)
After-hours: Aug 20, 2026, 5:21 PM EDT

BioStem Technologies Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
34.5947.4869.6616.696.884.34
Revenue Growth
-49.13%-31.84%317.48%142.69%58.38%1284.88%
Gross Profit
27.6544.4455.9215.425.992.87
Operating Income
-23.34-0.6931.12-7.06-4.68-1.61
Net Income
-28.29-6.5831.03-8.48-7.19-1.45
Earnings Per Share
-1.67-0.391.43-0.62-0.63-0.12
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
6.9629.5522.830.240.770.34
Total Debt
1.223.334.394.775.214.89
Net Cash (Debt)
5.7426.2218.44-4.53-4.44-4.55
Net Cash Growth
-78.94%42.20%----
Net Cash Per Share
0.341.570.85-0.33-0.39-0.39

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-5.929.9424.46-3.50.3-0.11
Capital Expenditures
-2.91-3.35-0.43-0.11-0.24-0.04
Free Cash Flow
-8.836.5924.04-3.60.06-0.15
Free Cash Flow Growth
--72.59%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
79.94%93.59%80.27%92.44%87.17%66.03%
Operating Margin
-67.47%-1.45%44.68%-42.30%-68.09%-36.99%
Pretax Margin
-68.35%-0.82%43.83%-50.84%-105.19%-32.52%
Profit Margin
-81.80%-13.86%44.55%-50.84%-104.62%-33.30%
FCF Margin
-25.54%13.88%34.51%-21.60%0.87%-3.51%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--7.43---
Forward PE
-18.146.858.6223.44-
P/FCF Ratio
-9.719.59-606.05-
PS Ratio
1.901.353.315.695.292.28